Analyst Ratings for Karyopharm Therapeutics (KPTI) [Sells]
KPTI Rating Summary
KPTI Price Target Summary
- Highest: $10.00 (H.C. Wainwright)
- Lowest: $3.00 (RBC Capital)
- Average: $5.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.67 (+342.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
Rating Score: 7.1 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2019 | BofA Securities | Ying Huang | Downgrade | Underperform (Neutral) |
5.00 (15.00) |
4.87 (1.28) |
-73.72% | Details |
